LY-2940094 | m-entrepreneurship.com

Product Name :
LY-2940094

Search keywords :
LY2940094

drugId :
null

Target Vo:
Nociceptin receptor

Target Vo Short Name :
OOR

Moa_Name:
Nociceptin receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Brown University

Active Indication_Name:
Depressive Disorder, Major

In Active Indication_Name:
Motor Disorders

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TSG101 Antibody
TAK1 Antibody (YA663)
Doublecortin Antibody: Doublecortin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to Doublecortin. It can be used for WB,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts